| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/25/2001 | WO2001005436A1 Method for producing antibodies in egg yolk and use of resulting antibodies |
| 01/25/2001 | WO2001005427A1 Psca: prostate stem cell antigen and uses thereof |
| 01/25/2001 | WO2001005426A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | WO2001005425A2 Combined preparations comprising daunorubicin derivatives and her2 antibodies |
| 01/25/2001 | WO2000071566A3 Novel organic anion transport proteins |
| 01/25/2001 | WO2000062817A3 Inducible vaccines |
| 01/25/2001 | WO2000061171A3 Uses of mammalian ox2 protein and related reagents |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000058472A3 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 01/25/2001 | WO2000057837A3 Compositions and methods for effecting the levels of cholesterol |
| 01/25/2001 | WO2000049139A3 A caspase activated protein kinase |
| 01/25/2001 | DE19934603A1 Regulatorisches Protein pKe#165 aus humanen Keratinozyten Regulatory protein pKe # 165 from human keratinocytes |
| 01/25/2001 | DE19930959A1 Neue Antimycotika und Fungizide, Verfahren zu deren Herstellung und Verwendung New antimycotics and fungicides, processes for their preparation and use |
| 01/25/2001 | CA2381961A1 Splice variants of cd40-receptor |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2379983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | CA2379968A1 Gtp-binding protein associated factors |
| 01/25/2001 | CA2379580A1 Novel human calcium sensitive potassium channel subunits |
| 01/25/2001 | CA2379391A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | CA2379349A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | CA2379129A1 Fima pilus-based vaccines |
| 01/25/2001 | CA2379069A1 Fimh adhesin-based vaccines |
| 01/25/2001 | CA2378946A1 Psca: prostate stem cell antigen and uses thereof |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2340721A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/24/2001 | EP1070962A2 Method for detecting low density lipoprotein (LDL) or denatured low density lipoprotein in blood |
| 01/24/2001 | EP1070141A1 Immediate early genes and methods of use therefor |
| 01/24/2001 | EP1070133A2 Biological material with increased expression of endogenous complement regulatory molecules |
| 01/24/2001 | EP1070131A1 Ubiquitin conjugating enzyme |
| 01/24/2001 | EP1070129A2 Dadd, death activator death domain protein |
| 01/24/2001 | EP1070128A1 Axor4 g-protein-coupled receptor |
| 01/24/2001 | EP1070126A1 Epitope-driven human antibody production and gene expression profiling |
| 01/24/2001 | EP1070125A2 Human nucleic acid sequences from normal breast tissue |
| 01/24/2001 | EP1070121A1 The cytokine family member ef-7 |
| 01/24/2001 | EP1070081A1 Novel molecules of the t129-related protein family and uses thereof |
| 01/24/2001 | EP1070080A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 01/24/2001 | EP1069907A1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 01/24/2001 | EP1069827A1 Nucleic acids encoding outer membrane protein of human granulocytic ehrlichiosis agent |
| 01/24/2001 | EP0820471B1 Antibodies against heart muscle actin |
| 01/24/2001 | EP0788513B1 Use of binding agents to cd23 in the treatment of autoimmune diseases |
| 01/24/2001 | EP0676964B1 Nitrosylation of enzyme sh groups as a therapeutic modality |
| 01/24/2001 | EP0630260B1 Polysaccharide-protein conjugates |
| 01/24/2001 | CN1281508A Human Sel-10 polypeptides and polynucleotides that encode them |
| 01/24/2001 | CN1281468A Treatment with anti-ErbB2 antibodies |
| 01/24/2001 | CN1281371A Method for obtaining vaccines for preventing pathogenic effects related to retroviral infection |
| 01/24/2001 | CN1281366A Prevention and treatment of amyloidogenic disease |
| 01/24/2001 | CN1281047A Human limb deformation protein and its coding sequence |
| 01/24/2001 | CN1281046A Human growth or deformation dependent protein and its coding sequence |
| 01/24/2001 | CN1281045A Human fibrous surface structure subunit protein and its coding sequence |
| 01/24/2001 | CN1281044A Human translation initiation factor protein and its coding sequence |
| 01/24/2001 | CN1281043A Human early endosome antigen protein isomer and its coding sequence |
| 01/24/2001 | CN1281042A Human carboxylpeptidase protein and its coding sequence |
| 01/24/2001 | CN1281041A Human complement component subunit chain protein isomer and its coding sequence |
| 01/24/2001 | CN1281040A Human actin associated protein compound subunit protein and its coding sequence |
| 01/24/2001 | CN1281039A Human ribosome subunit protein and its coding sequence |
| 01/24/2001 | CN1280833A Process for preparing multi-strain antibody from waterfowls |
| 01/23/2001 | US6177615 Lepidopteran-toxic polypeptide and polynucleotide compositions and methods for making and using same |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177548 Enhanced aggregate removal from bulk biologicals using ion exchange chromatography |
| 01/23/2001 | US6177547 The specified glycoprotein ligand comprising a fucosylated sialylated glycoprotein containing sialyl lewis x antigen; antibody has binding specific for p-selectin glycoprotein ligand; use modifying inflammatory process, diagnostic assays |
| 01/23/2001 | US6177545 Antibody which preferentially binds an epitope of an enzymatic protein; for diagnosis of time events in tumor propagation and metastasis, autoimmune diseases, kidney defects and atherosclerotic injury |
| 01/23/2001 | US6177543 Homogeneous human lymphokines; for the treatment of tumors; antitumor agents |
| 01/23/2001 | US6177468 Modulation of inflammation related to columnar epithelia |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177258 Amino acid sequences of protein; for screening enzyme inhibitors for use as parasiticides/insecticides; veterinary medicine |
| 01/23/2001 | US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/23/2001 | US6177253 Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24 |
| 01/23/2001 | US6177087 Administering a polymer conjugate |
| 01/23/2001 | US6177081 Human and marmoset activating viruses |
| 01/23/2001 | US6177080 Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy |
| 01/23/2001 | US6177079 Monoclonal antibodies against interleukins |
| 01/23/2001 | US6177078 Binding interleukins |
| 01/23/2001 | US6177077 TNT inhibitors for the treatment of neurological disorders |
| 01/23/2001 | CA2296884C Targeted liposomes and methods for liposome-protein coupling |
| 01/23/2001 | CA2122473C Nuclear matrix protein fluid assay |
| 01/18/2001 | WO2001004326A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004317A1 Ompa gene for an outer membrane protein of riemerella anatipestifer and methods of use |
| 01/18/2001 | WO2001004316A2 Antigenic meningococcal peptides |
| 01/18/2001 | WO2001004311A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2001 | WO2001004309A1 T-CELL RECEPTOR η ALTERNATE READING FRAME PROTEIN, (TARP) AND USES THEREOF |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004306A1 Expression vectors and methods |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004304A1 Human cytokine receptor |
| 01/18/2001 | WO2001004302A1 Atopy gene |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004296A1 Rbp1 polypeptides and uses thereof |
| 01/18/2001 | WO2001004292A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | WO2001004269A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | WO2001004160A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 01/18/2001 | WO2001004159A1 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 01/18/2001 | WO2001004158A1 Method for determining dna double-stranded breaks |
| 01/18/2001 | WO2001004157A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004150A2 Neisseria meningitidis compounds and anti-infection applications thereof |